Ailbhe O'Brien

Ailbhe O'Brien, PhD, is currently the Associate Director of Regulatory Medical Writing at Eli Lilly and Company, where they lead the writing process for complex regulatory documents. Ailbhe is also on a British Heart Foundation studentship at King’s College London, investigating TTN mutations related to dilated cardiomyopathy using a zebrafish model. They earned a PhD in Cardiovascular Science from King’s College London, following a Master of Research in the same field. Earlier, Ailbhe conducted research on retinopathy of prematurity as a visiting research student at Queen's University Belfast.